AGM Statement

RNS Number : 1471E
Imperial Brands PLC
07 February 2018
 

IMPERIAL BRANDS PLC

AGM Update 

 

7 February 2018

 

Ahead of its Annual General Meeting today, Imperial Brands PLC issued the following update.

 

We remain on track to meet constant currency net revenue and earnings expectations for the full year. As highlighted in November, delivery will be weighted to the second half. We continue to realise further share gains in our Growth Brands and in the majority of our priority markets, building on the success of last year's marketing investment programme. This is delivering a robust volume performance, reflecting overall share growth. The first half though will reflect some negative price/mix impacts, particularly post EUTPD in UK and post excise increases in France.  As also highlighted, we are significantly stepping up our level of activity in Next Generation Products (NGP), with multiple launches in the next few months.

 

NGP Update

We are prioritising e-vapour growth by further developing blu, which is currently available in the USA, UK, Italy and France. We are adding to blu's growth potential in these markets and extending the brand into new markets, with the launch of a pod system, 'myblu'. This is part of a significant portfolio development, improving the consumer experience and therefore conversion potential. The innovation strengths of our recently acquired business, Nerudia, are already adding to our exciting pipeline of developments that will continue to improve our consumer offering.

 

myblu was recently launched in the USA, generating an excellent response from consumers, with online pre-orders rapidly selling out. myblu uses a one-click liquid pod system, which is the fastest growing e-vapour segment in the USA. Launches are also being finalised for France, UK, Russia and Italy and, by the end of the financial year, myblu will be available in at least 10 markets, with this figure set to double in FY19.

 

Trials of heated tobacco products in Europe and Japan have received very positive consumer feedback.  We are currently evaluating the results and are refining our heated tobacco offerings in advance of more comprehensive testing in the coming months.

 

Group Net Revenue

Constant currency net revenue growth for the full year is expected to be in line with our medium-term guidance, reflecting growth in tobacco sales and the expansion of our NGP business. First half constant currency net revenue is expected to benefit from continued share gains in our priority markets and improved pricing. This will be more than offset by adverse mix and lower Fontem intellectual property licensing income (£35m). We expect second half net revenues to be stronger due to improved price/mix in tobacco and an increasing contribution from e-vapour products.

 

Group Adjusted Operating Profit

First half constant currency adjusted operating profit will also reflect these net revenue dynamics. As previously announced, reported operating profit will be impacted by a write-off of up to around £160m as a result of the UK wholesaler, Palmer & Harvey (P&H), entering administration last November. Due to the size and non-recurring nature of this write-off, it will be excluded from adjusted measures. We anticipate first half non-operating income to be matched at a similar level to last year (Logista bank shares and US post-retirement benefits totalling £33m). Full year adjusted operating profit (excluding the P&H write-off) is anticipated to be weighted more to the second half than last year at constant currency (2017: 46:54).

 

The strengthening of sterling at current rates is expected to result in a currency translation headwind on net revenue and adjusted profit of about 3.5% at the half year and 2.5-3.0% at the full year.  Cash generation remains strong underpinning our 10% dividend growth.

 

 

 

ENDS

 

 

 

 

Investor Contacts

Media Contacts

Peter Durman

+44 (0)7970 328 903

Alex Parsons

+44 (0)7967 467 241

Matt Sharff

+44 (0)117 933 7396

Simon Evans

+44 (0)7967 467 684

Mat Slade

+44 (0)117 332 2504



 

 

 

 

Cautionary Statement

Certain statements in this announcement constitute or may constitute forward-looking statements. Any statement in this announcement that is not a statement of historical fact including, without limitation, those regarding the Company's future expectations, operations, financial performance, financial condition and business is or may be a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected or implied in any forward-looking statement. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this announcement. As a result, you are cautioned not to place any reliance on such forward-looking statements. The forward-looking statements reflect knowledge and information available at the date of this announcement and the Company undertakes no obligation to update its view of such risks and uncertainties or to update the forward-looking statements contained herein. Nothing in this announcement should be construed as a profit forecast or profit estimate and no statement in this announcement should be interpreted to mean that the future earnings per share of the Company for current or future financial years will necessarily match or exceed the historical or published earnings per share of the Company. This announcement has been prepared for, and only for the members of the Company, as a body, and no other persons. The Company, its Directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this announcement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFKODQABKKDBK
UK 100

Latest directors dealings